分子医学将治疗技术提升为科学。 - Suppr

Suppr

超能文献

Molecular medicine hones therapeutic arts to science.

作者信息

Waldman S A, Terzic M R, Terzic A

出版信息

Clin Pharmacol Ther. 2007 Oct;82(4):343-7. doi: 10.1038/sj.clpt.6100360.

DOI:10.1038/sj.clpt.6100360

PMID:17851568

Abstract

摘要

相似文献

Molecular medicine hones therapeutic arts to science.

Clin Pharmacol Ther. 2007 Oct;82(4):343-7. doi: 10.1038/sj.clpt.6100360.

Drug discovery and development in the age of molecular medicine.

Clin Pharmacol Ther. 2007 Oct;82(4):363-6. doi: 10.1038/sj.clpt.6100333.

Personalized medicine: elusive dream or imminent reality?

Clin Pharmacol Ther. 2007 Jun;81(6):807-16. doi: 10.1038/sj.clpt.6100204.

Beyond genomics.

Clin Pharmacol Ther. 2007 Oct;82(4):366-70. doi: 10.1038/sj.clpt.6100363.

Pharmacogenomics: the promise of personalized medicine.

Environ Health Perspect. 2003 Aug;111(11):A581-9. doi: 10.1289/ehp.111-1241640.

Is cell and molecular biology divorcing from clinical practice?

Am J Respir Crit Care Med. 2003 May 1;167(9):1164-5. doi: 10.1164/rccm.2301003.

Anesthesia: a discipline that incorporates clinical pharmacology across the DDRU continuum.

Clin Pharmacol Ther. 2008 Jul;84(1):3-6. doi: 10.1038/clpt.2008.99.

Molecular medicine: how, what, and when?

Clin Pharmacol Ther. 2007 Oct;82(4):376-8. doi: 10.1038/sj.clpt.6100349.

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):226-34.

Getting to personalized cancer medicine: taking out the garbage.

Cancer. 2007 Oct 15;110(8):1641-3. doi: 10.1002/cncr.22966.

引用本文的文献

Induced pluripotent stem cells: advances to applications.

Stem Cells Cloning. 2010 Jan 1;3:29-37. doi: 10.2147/SCCAA.S4954.

Experimental therapeutics: a paradigm for personalized medicine.

Clin Transl Sci. 2009 Dec;2(6):436-8. doi: 10.1111/j.1752-8062.2009.00146.x.

Applications of microRNA in cancer: Exploring the advantages of miRNA.

Clin Transl Sci. 2009 Jun;2(3):248-9. doi: 10.1111/j.1752-8062.2009.00110.x.

Translational medicine in the era of health care reform.

Clin Transl Sci. 2009 Apr;2(2):96-7. doi: 10.1111/j.1752-8062.2009.00104.x.

Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Clin Transl Sci. 2009 Feb;2(1):6-8. doi: 10.1111/j.1752-8062.2008.00067.x.

The roadmap to personalized medicine.

Clin Transl Sci. 2008 Sep;1(2):93. doi: 10.1111/j.1752-8062.2008.00045.x.

Clinical and translational sciences: at the intersection of molecular and individualized medicine.

Clin Transl Sci. 2008 May;1(1):6-8. doi: 10.1111/j.1752-8062.2008.00019.x.

Stem cell platforms for regenerative medicine.

Clin Transl Sci. 2009 Jun;2(3):222-7. doi: 10.1111/j.1752-8062.2009.00096.x.

Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

Clin Transl Sci. 2008 Sep;1(2):168-171. doi: 10.1111/j.1752-8062.2008.00039.x.

The advancement of translational medicine-from regional challenges to global solutions.

Nat Med. 2009 Sep;15(9):1006-9. doi: 10.1038/nm0909-1006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Molecular medicine hones therapeutic arts to science.

Clin Pharmacol Ther. 2007 Oct;82(4):343-7. doi: 10.1038/sj.clpt.6100360.

Drug discovery and development in the age of molecular medicine.

Clin Pharmacol Ther. 2007 Oct;82(4):363-6. doi: 10.1038/sj.clpt.6100333.

Personalized medicine: elusive dream or imminent reality?

Clin Pharmacol Ther. 2007 Jun;81(6):807-16. doi: 10.1038/sj.clpt.6100204.

Beyond genomics.

Clin Pharmacol Ther. 2007 Oct;82(4):366-70. doi: 10.1038/sj.clpt.6100363.

Pharmacogenomics: the promise of personalized medicine.

Environ Health Perspect. 2003 Aug;111(11):A581-9. doi: 10.1289/ehp.111-1241640.

Is cell and molecular biology divorcing from clinical practice?

Am J Respir Crit Care Med. 2003 May 1;167(9):1164-5. doi: 10.1164/rccm.2301003.

Anesthesia: a discipline that incorporates clinical pharmacology across the DDRU continuum.

Clin Pharmacol Ther. 2008 Jul;84(1):3-6. doi: 10.1038/clpt.2008.99.

Molecular medicine: how, what, and when?

Clin Pharmacol Ther. 2007 Oct;82(4):376-8. doi: 10.1038/sj.clpt.6100349.

Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.

Curr Opin Drug Discov Devel. 2010 Mar;13(2):226-34.

Getting to personalized cancer medicine: taking out the garbage.

Cancer. 2007 Oct 15;110(8):1641-3. doi: 10.1002/cncr.22966.

引用本文的文献

Induced pluripotent stem cells: advances to applications.

Stem Cells Cloning. 2010 Jan 1;3:29-37. doi: 10.2147/SCCAA.S4954.

Experimental therapeutics: a paradigm for personalized medicine.

Clin Transl Sci. 2009 Dec;2(6):436-8. doi: 10.1111/j.1752-8062.2009.00146.x.

Applications of microRNA in cancer: Exploring the advantages of miRNA.

Clin Transl Sci. 2009 Jun;2(3):248-9. doi: 10.1111/j.1752-8062.2009.00110.x.

Translational medicine in the era of health care reform.

Clin Transl Sci. 2009 Apr;2(2):96-7. doi: 10.1111/j.1752-8062.2009.00104.x.

Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Clin Transl Sci. 2009 Feb;2(1):6-8. doi: 10.1111/j.1752-8062.2008.00067.x.

The roadmap to personalized medicine.

Clin Transl Sci. 2008 Sep;1(2):93. doi: 10.1111/j.1752-8062.2008.00045.x.

Clinical and translational sciences: at the intersection of molecular and individualized medicine.

Clin Transl Sci. 2008 May;1(1):6-8. doi: 10.1111/j.1752-8062.2008.00019.x.

Stem cell platforms for regenerative medicine.

Clin Transl Sci. 2009 Jun;2(3):222-7. doi: 10.1111/j.1752-8062.2009.00096.x.

Strategies for therapeutic repair: The "R(3)" regenerative medicine paradigm.

Clin Transl Sci. 2008 Sep;1(2):168-171. doi: 10.1111/j.1752-8062.2008.00039.x.

The advancement of translational medicine-from regional challenges to global solutions.

Nat Med. 2009 Sep;15(9):1006-9. doi: 10.1038/nm0909-1006.